• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.


    Find out more about it and REGISTER today!

  • 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Dementia Management Update"

    (session captured at the GAPNA 2018 Annual Conference)

    For September/October 2019 - Get Your Free CNE Now!

Key Treatments for High Blood Pressure and High Blood Lipids Do Not Reduce Elderly Patients' Risk of Limited Mobility

Use of angiotensin-converting enzyme (ACE) inhibitors and statins do not reduce the risk of impaired mobility in older adults, a new study finds.

Impairments in mobility are common in older adults, with 15% of older men and 23% of older women unable to walk two to three blocks.

Chronic inflammation has been identified as a factor leading to a decline in functional status, including mobility. Both ACE inhibitors and statins may decrease systemic inflammation

In addition, ACE inhibitors may have a direct effect on muscle mass.

To see if these medications would indirectly have a positive impact on mobility, the researchers followed 3,055 healthy older adults, who had no mobility problems at baseline, for 6.5 years.

At baseline, the participants were in their 70s and had no difficulty walking a quarter-mile, climbing 10 steps, or performing basic activities of daily living; 15.2% used ACE inhibitors and 12.9% used statins. By year 6, ACE inhibitor use increased to 25.6% and statin use to 28.6%.

At the end of the 6.5-year study, 49.8% of the remaining adults had developed mobility limitation.

In separate multivariable models, neither ACE inhibitor use nor statin use was significantly associated with lower risk of mobility limitation.

For more info, see Gray et al. (2011). iAngiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: The Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 59(12), 2226-2232.

Related Topic 1: 

GAPNA Newsletter Issue: